Michael Phan

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research, GigaGen (United States)

MedicineHealth ProfessionsPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Updates in SJS/TEN: collaboration, innovation, and community”.

Updates in SJS/TEN: collaboration, innovation, and community

Frontiers in Medicine(2023)10.3389/fmed.2023.1213889

N/A

0DataRank · unranked

34 citations

Ramya Krishna Botta, Riichiro Abe, Thomas M. Beachkofsky, Isabelle Boothman, Bruce Carleton +57 more

Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010–2020: A Cross-Sectional Study

Therapeutic Innovation & Regulatory Science(2023)10.1007/s43441-023-00542-0

N/A

0DataRank · unranked

11 citations

Carmen Cheng, Vivian Dang, Eileen Wu, Mónica Muñoz, Michael Phan